Ocugen, Inc. Files 8-K Report
Ticker: OCGN · Form: 8-K · Filed: Jun 17, 2025 · CIK: 1372299
| Field | Detail |
|---|---|
| Company | Ocugen, INC. (OCGN) |
| Form Type | 8-K |
| Filed Date | Jun 17, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, filing, corporate-update
TL;DR
Ocugen filed an 8-K on 6/16/25. Standard update.
AI Summary
On June 16, 2025, Ocugen, Inc. filed an 8-K report detailing other events and financial statements. The company, incorporated in Delaware, is involved in biological products, specifically excluding diagnostic substances, and is headquartered at 11 Great Valley Parkway, Malvern, PA.
Why It Matters
This filing provides an update on Ocugen's corporate activities and financial reporting, which is crucial for investors to stay informed about the company's status.
Risk Assessment
Risk Level: low — This filing is a routine 8-K report and does not contain significant new information that would inherently increase risk.
Key Numbers
- 001-36751 — SEC File Number (Identifies Ocugen's filing with the SEC.)
- 1231 — Fiscal Year End (Indicates the end of Ocugen's financial reporting year.)
Key Players & Entities
- Ocugen, Inc. (company) — Registrant
- June 16, 2025 (date) — Date of Earliest Event Reported
- Delaware (jurisdiction) — State of Incorporation
- 11 Great Valley Parkway Malvern, Pennsylvania 19355 (address) — Business Address
- 484-328-4701 (phone_number) — Business Phone
FAQ
What is the primary purpose of this 8-K filing?
This 8-K filing is to report 'Other Events' and 'Financial Statements and Exhibits' as of June 16, 2025.
What is Ocugen, Inc.'s state of incorporation?
Ocugen, Inc. is incorporated in Delaware.
What is the business address and phone number for Ocugen, Inc.?
The business address is 11 Great Valley Parkway, Malvern, Pennsylvania 19355, and the phone number is (484) 328-4701.
What is the SIC code for Ocugen, Inc.?
The Standard Industrial Classification (SIC) code is 2836, which pertains to Biological Products (No Diagnostic Substances).
When was the earliest event reported in this filing?
The earliest event reported in this filing occurred on June 16, 2025.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 17, 2025 regarding Ocugen, Inc. (OCGN).